India has earned its title as the “pharmacy of the world” — and for good reason. The country supplies approximately one-fifth of global generic medicines by volume, exports pharmaceuticals to over 200 countries, and is the world’s largest vaccine manufacturer. As of 2024–25, the Indian pharmaceutical industry is valued at around $65 billion and is projected to reach $130 billion by 203. Behind this remarkable growth story are hundreds of companies, but a select group of industry giants leads the charge.
Here is a comprehensive look at the top 30 pharma companies in India, covering domestic powerhouses, multinational players, and rising stars shaping the future of healthcare.
Table of Contents
1. Sun Pharmaceutical Industries Ltd.
The undisputed No. 1 pharma company in India by market capitalisation, Sun Pharma is also among the top 10 generic drug manufacturers globally. Headquartered in Mumbai, it operates across specialty, generics, and APIs in over 100 countries.
2. Dr. Reddy’s Laboratories
Based in Hyderabad, Dr. Reddy’s reported revenues of approximately ₹31,229 crore in FY2025. It is a global leader in generics and biosimilars, with a strong footprint in the US, Europe, and emerging markets.
3. Cipla Ltd.
One of India’s most trusted pharma brands, Cipla is renowned for its respiratory therapies and anti-HIV medications. It has a significant international presence and supplies branded prescription drugs, trade generics, and consumer health products globally.
4. Divi’s Laboratories Ltd.
A specialist in Active Pharmaceutical Ingredients (APIs) and intermediates, Divi’s Labs is one of India’s top exporters. Exports account for nearly 87% of its revenue, with Europe and the US being the largest markets.
5. Lupin Ltd.
Mumbai-headquartered Lupin is one of the world’s largest generic drug companies by revenue. With over 1,400 scientists at its R&D hub near Pune, the company covers paediatrics, anti-infectives, asthma, and cardiovascular therapies across more than 100 countries.
6. Aurobindo Pharma Ltd.
Based in Hyderabad, Aurobindo posted net sales of ₹30,921 crore in FY2025, driven largely by exports to the US and Europe. The company showed a 15.61% revenue increase in Q3 FY2025 alone, reflecting robust global momentum.
7. Torrent Pharmaceuticals Ltd.
Founded in 1959 and headquartered in Ahmedabad, Torrent Pharma is the first Indian company to hold the highest market share in both Germany and Brazil. It offers over 2,000 products across cardiovascular, CNS, and gastro-intestinal categories in 50+ countries.
8. Zydus Lifesciences Ltd.
Formerly Cadila Healthcare, Zydus is known for its innovation-driven approach, including India’s first indigenously developed COVID-19 DNA vaccine, ZyCoV-D. It operates across generics, biosimilars, and new chemical entities.
9. Mankind Pharma Ltd.
Delhi-based Mankind is India’s fourth-largest pharma company by sales. It is widely known for consumer healthcare products such as Manforce, Prega News, and Unwanted-72, and operates 25 factories across India.
10. Biocon Ltd.
Headquartered in Bangalore, Biocon is India’s leading biopharmaceutical company. It focuses on biosimilars for oncology, diabetes, and immunology, with a global presence spanning the US, Europe, and emerging markets.
11. Alkem Laboratories Ltd.
Mumbai-based Alkem is one of India’s top domestic pharma brands, known for anti-infectives, vitamins, and pain management drugs. It has a strong rural reach and a growing international business.
12. Glenmark Pharmaceuticals Ltd.
With operations in over 80 countries, Glenmark specialises in respiratory, dermatology, and oncology. The company is known for Ryaltris nasal spray and COVID-19 antiviral FabiFlu, and operates four R&D centres in India.
13. Abbott India Ltd.
A subsidiary of global healthcare giant Abbott, Abbott India has a strong presence in women’s health, metabolics, gastroenterology, and CNS segments. It is consistently among the top companies in the Indian domestic market.
14. Ipca Laboratories Ltd.
Ipca is a vertically integrated pharma company with expertise in APIs and formulations, and is a key supplier of anti-malarial and anti-rheumatic drugs in global markets.
15. Emcure Pharmaceuticals Ltd.
Pune-based Emcure focuses on HIV antivirals, gynaecology, oncology, and haematology. It distributes over 350 brands globally and has 13 manufacturing facilities and five R&D centres in India.
16. Laurus Labs Ltd.
Hyderabad’s Laurus Labs is known for its API synthesis and formulation capabilities, especially in antiretrovirals, oncology, and generic formulations for regulated markets.
17. Ajanta Pharma Ltd.
Mumbai-based Ajanta specialises in branded generics across ophthalmology, dermatology, and cardiology. It has a strong presence in the emerging markets of Africa and Southeast Asia.
18. JB Chemicals & Pharmaceuticals Ltd.
Known for its cardiology, gastroenterology, and respiratory portfolio, JB Chemicals has grown significantly in both domestic and international markets in recent years.
19. Gland Pharma Ltd.
A leading injectables-focused company headquartered in Hyderabad, Gland Pharma has one of the largest injectable-only manufacturing capacities in India, exporting heavily to the US and Europe.
20. Sai Life Sciences Ltd.
A contract research, development, and manufacturing organisation (CRDMO), Sai Life Sciences serves global pharmaceutical and biotech companies with integrated drug discovery and development services.
21. Natco Pharma Ltd.
Hyderabad-based Natco is known for oncology generics and first-to-file ANDAs in the US. It has collaborated globally to provide affordable access to cancer treatments.
22. Pfizer India Ltd.
The Indian arm of global pharma giant Pfizer, Pfizer India contributes to the country’s pharmaceutical ecosystem with an extensive portfolio in vaccines, oncology, and internal medicines.
23. GlaxoSmithKline Pharmaceuticals Ltd. (GSK India)
GSK India’s portfolio includes vaccines, respiratory, and consumer healthcare products. It plays a significant role in national immunisation programmes.
24. Wockhardt Ltd.
Mumbai-based Wockhardt has a strong presence in anti-infectives and neurology. The company operates multiple manufacturing plants approved by global regulatory bodies including the US FDA and UK MHRA.
25. Granules India Ltd.
Granules specialises in APIs, pharmaceutical formulation intermediates, and finished dosages. Its vertically integrated model gives it a competitive edge in cost-efficient manufacturing.
26. Strides Pharma Science Ltd.
Bangalore-headquartered Strides focuses on regulated markets — particularly the US and Australia — with a strong oncology and specialty injectables pipeline.
27. Eris Lifesciences Ltd.
Ahmedabad-based Eris has carved a strong niche in chronic lifestyle disease segments such as cardiology, diabetes, and neurology in the Indian domestic market.
28. Solara Active Pharma Sciences Ltd.
A pure-play API manufacturer, Solara serves global pharmaceutical companies with a diverse portfolio of molecules across pain, CNS, and anti-diabetic categories.
29. Arbro Pharmaceuticals Ltd.
Delhi-based Arbro offers over 700 branded and generic formulations for human and veterinary use, while also serving as a contract manufacturer and one of India’s leading safety-testing providers.
30. Serum Institute of India
No list of Indian pharma would be complete without Serum Institute — the world’s largest vaccine manufacturer by number of doses produced. Based in Pune, it supplies vaccines to over 170 countries and has been pivotal in global immunisation campaigns.
Why India’s Pharma Sector Stands Apart
Several factors underpin India’s pharmaceutical dominance. The country hosts the **largest number of FDA-approved manufacturing facilities outside the United States**, ensuring global quality compliance. It accounts for **8% of the world’s API production**, supplies over **80% of antiretroviral drugs** used globally to combat HIV/AIDS, and meets 99% of the WHO’s demand for DPT vaccines.
Indian companies are rapidly advancing in biosimilars — a segment projected to grow at a CAGR of 22% — and are investing in AI-driven drug discovery, digital manufacturing, and biologics. The government’s Production-Linked Incentive (PLI) schemes and the development of bulk drug parks are further catalysing growth.
The Indian pharmaceutical sector is no longer just a generics hub; it is evolving into a global innovation centre. These 30 companies are not just businesses — they are pillars of public health, both in India and across the world.
